or Try an Advanced Search...

    Technical Analysis for AVIR - Atea Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 3.71 0.00% 0.00
    AVIR closed down 6.31 percent on Wednesday, May 15, 2024, on 2.52 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical AVIR trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
    Slingshot Bullish Bullish Swing Setup 0.00%
    Gapped Down Weakness 0.00%
    Upper Bollinger Band Walk Strength -6.31%
    Upper Bollinger Band Touch Strength -6.31%
    180 Bullish Setup Bullish Swing Setup -8.17%
    Upper Bollinger Band Touch Strength -8.17%
    50 DMA Support Bullish -4.63%
    Older End-of-Day Signals for AVIR ...

       Recent Intraday Alerts

    Alert Time
    Gap Down Partially Closed about 2 hours ago
    Gap Down Closed about 2 hours ago
    Reversed from Down about 2 hours ago
    Gapped Down (Partial) about 2 hours ago
    Down 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    AVIR Chart by TradingView
    Basic chart:

    Profile

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology

    Is AVIR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Atea Pharmaceuticals Inc (AVIR) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
    May 15 Atea Pharmaceuticals, Inc. (AVIR) Q1 2024 Earnings Call Transcript
    May 14 Atea Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
    May 14 Atea Pharmaceuticals GAAP EPS of -$0.75 misses by $0.14
    May 14 Atea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
    May 7 Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024
    Apr 29 Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
    Mar 27 Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
    Feb 29 Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript
    Feb 29 Atea Pharmaceuticals, Inc. (AVIR) Q4 2023 Earnings Call Transcript
    See more AVIR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.19
    52 Week Low 2.765
    Average Volume 288,393
    200-Day Moving Average 3.49
    50-Day Moving Average 3.87
    20-Day Moving Average 3.82
    10-Day Moving Average 3.92
    Average True Range 0.14
    RSI (14) 41.86
    ADX 22.63
    +DI 24.06
    -DI 22.73
    Chandelier Exit (Long, 3 ATRs) 3.71
    Chandelier Exit (Short, 3 ATRs) 4.08
    Upper Bollinger Bands 4.06
    Lower Bollinger Band 3.57
    Percent B (%b) 0.28
    BandWidth 12.86
    MACD Line 0.02
    MACD Signal Line 0.01
    MACD Histogram 0.0074
    Fundamentals Value
    Market Cap 309.55 Million
    Num Shares 83.4 Million
    EPS -1.57
    Price-to-Earnings (P/E) Ratio -2.36
    Price-to-Sales 1.90
    Price-to-Book 0.61
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.12
    Resistance 3 (R3) 4.15 4.03 4.05
    Resistance 2 (R2) 4.03 3.93 4.02 4.03
    Resistance 1 (R1) 3.87 3.86 3.82 3.85 4.01
    Pivot Point 3.76 3.76 3.73 3.75 3.76
    Support 1 (S1) 3.60 3.65 3.54 3.57 3.41
    Support 2 (S2) 3.48 3.59 3.47 3.39
    Support 3 (S3) 3.32 3.48 3.37
    Support 4 (S4) 3.30